Kapil Dhingra

Director · Replimune Group

Kapil Dhingra (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Replimune Group, Inc. (REPL). The largest single filing was $408K of REPL (21,500 sh × $19.00, as filed), executed Nov 2. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$408K

shares × price, as filed

Last traded

Nov 2

Filed Nov 3

Median ADV $90.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $408K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

REPL

Replimune Group, Inc. REPL · 0 buys · 1 sell 1 filing

Recent filings

REPLSALE Replimune Group, Inc. View filing → $408K
21,500 sh × $19.00
Exec Nov 2
Filed Nov 3 · 8:43 PM ET